Novo Nordisk A/S (NOVOB) Given Neutral Rating at JPMorgan Chase & Co.

JPMorgan Chase & Co. reaffirmed their neutral rating on shares of Novo Nordisk A/S (SWX:NOVOB) in a research note published on Friday.

Separately, Goldman Sachs Group reiterated a buy rating on shares of Novo Nordisk A/S in a research note on Wednesday.

NOVOB remained flat at $€47.79 ($55.57) during trading hours on Friday. Novo Nordisk A/S has a 1-year low of €33.43 ($38.87) and a 1-year high of €56.35 ($65.52).

Featured Article: What does EPS mean?

Receive News & Ratings for Novo Nordisk A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novo Nordisk A/S and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply